Contrast-induced nephropathy and cardiac catheterization: Evidence in support of using the iso-osmolar contrast agent iodixanol in patients with renal dysfunction

Journal of Invasive Cardiology

Volumn 17, Issue 4, 2005, Pages 216-217

  Ilkhanoff, Leonard ^a   Carver, Joseph ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ATRIAL NATRIURETIC FACTOR; CONTRAST MEDIUM; CREATININE; FENOLDOPAM; IODIXANOL; IOHEXOL; THEOPHYLLINE;

ANGIOCARDIOGRAPHY; CREATININE BLOOD LEVEL; DRUG SAFETY; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; KIDNEY DISEASE; KIDNEY DYSFUNCTION; NOTE; OSMOLARITY;

CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; HEART CATHETERIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; OSMOLAR CONCENTRATION; RISK FACTORS; TRIIODOBENZOIC ACIDS;

EID: 16844362870     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (13)

1. Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: Review focusing on prevention. J Am Coll Cardiol 2004;44:1763-1771.
2. Stone GW, McCullough PA, Tumlin JA, et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: A randomized controlled trial. JAMA 2003;290:2284-2291.
3. Kurnik BR, Allgren RL, Genter FC. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998;31:674-680.
4. Abizaid AS, Clark CE, Mintz GS, et al. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with pre-existing renal insufficiency. Am J Cardiol 1999;83:260-263.
5. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-1420.
6. Baker CS, Wragg A, Kumar S, et al. A rapid protocol for the prevention of contrast-induced renal dysfunction: The RAPPID study. J Am Coll Cardiol 2003;41:2114-2118.
7. Alonso A, Lau J, Jaber BL, et al. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: A meta-analysis of randomized, controlled trials. Am J Kidney Dis 2004;43:1-9.
8. Tadros GM, Malik JA, Manske CL. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease. J Invas Cardiol 2005;17:211-215.
9. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-2264.
10. Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005;95:13-19.
11. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36:1542-1548.
12. Chalmers N, Jackson RW. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 1999;72:701-703.
13. Aspelin P, Aubry P, Fransson S-G, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491-499.